Confidential mandate

Regulated Training Evidence Architecture Director — Biopharmaceuticals

Planned Hiring / New

Regulated Training Evidence Architecture Director mandate in Basel, Switzerland · Biopharmaceutical Research and Manufacturing

A Basel biopharmaceutical group commissions a five-month engagement to connect controlled procedures, role qualification and learning evidence across research, manufacturing and quality workforces under inspection scrutiny.

The mandate

Controlled procedures are assigned through broad role codes, generating thousands of acknowledgements whose relevance and transfer are uncertain. Local sites add curricula outside the enterprise catalogue, contractors receive abbreviated pathways, and revised procedures may take effect before affected people demonstrate changed practice. Inspection responses repeatedly cite completion percentages without proving that the right population was ready at effective date.

The engagement deliverable is a Procedure-to-Qualification Evidence Architecture linking controlled document, changed task, affected role, person population, prerequisite, learning intervention, assessment, supervised practice, effective date, exception and deployment status. It must distinguish read-and-understand material from competence-changing content and preserve Quality’s authority over procedure effectiveness. Superseded instructions, translated content and delayed site adoption must remain traceable through each worker’s authorised state.

Milestone one at week four accepts procedure, role and curriculum populations; week eight approves impact and evidence rules. Week thirteen completes six representative process journeys; week eighteen rehearses a high-risk procedure revision. At week twenty-two, accepted artefacts, control catalogue, implementation backlog, steward training and a second unseen change trial conclude delivery.

Acceptance requires document owners to identify affected tasks and populations, learning owners to evidence the appropriate intervention, and Quality to prevent unauthorised work after effective date. The Global Quality Head signs only after client teams process twelve unfamiliar procedure changes without mass assignment, consultant mapping or retrospective completion dates.

The client will provide controlled document and role inventories, learning records, qualification matrices, change controls, effective dates, personnel populations, contractor routes, deviations, inspection findings, system interfaces and named owners. The consultant does not approve procedures, validate systems, certify individuals, perform Quality assurance, investigate deviations, deliver bulk training or configure production platforms.

Why this is external work

Document systems know what changed, learning systems know what was assigned and operations know who performs the task, but no layer joins them reliably. Independent architecture can establish consequence-based evidence without deciding Quality content, validating technology or turning every document revision into indiscriminate training. It also makes cross-site exceptions visible before an inspector discovers them.

What you will own

  • Map controlled procedures to changed tasks, affected role populations, sites, language versions, effective dates and consequence tiers.
  • Define acknowledgement, knowledge check, simulation, supervised practice and repeated observed qualification evidence by regulated change type.
  • Govern contractor, transfer, leave, new-hire and temporary-role populations through procedure effective dates.
  • Establish impact assessment, assignment, completion, exception, deployment restriction and retrospective review controls.
  • Reconcile document, role, learning, qualification and roster records for representative regulated processes.
  • Rehearse an urgent revision, phased site release, contractor substitution, system outage and failed assessment.
  • Deliver governed data relationships, decision rules, control specifications, cross-site training cases and prioritised implementation backlog with accountable owners.

Candidate qualifications

  • Designed regulated learning evidence across pharmaceutical research, clinical laboratories, sterile manufacturing and independent Quality operations.
  • Connected controlled-document changes with tasks, roles, multilingual populations, assessments, supervised practice and deployment restrictions.
  • Distinguished acknowledgement from robust competence evidence using consequence, recency and observed work-performance requirements.
  • Governed effective dates, superseded content, exceptions, contractors, transfers and system outages under direct inspection scrutiny.
  • Preserved boundaries among learning architecture, Quality approval, qualification, validation and investigation.
  • Transferred procedure-change governance through repeated client-run trials across materially different regulated processes and operating sites.

Non-negotiables

  • Can lead Basel evidence laboratories and all three controlled procedure-change trials within five months.
  • Brings procedure-to-qualification architecture in regulated life sciences; LMS administration alone is insufficient.
  • Will disclose learning platforms, validation vendors, training suppliers and quality-consulting relationships.
  • Will not approve procedures, validate systems, certify people, investigate deviations or deliver mass training.
  1. 49 words maximum. Describe a procedure revision where acknowledgement failed to prove changed practice.
  2. 49 words maximum. How did you identify affected people more precisely than broad role assignment?
  3. 49 words maximum. Which urgent effective-date event would you use for final acceptance?

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.